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Abstract
Background: Military and industrial activities have lead to reported release of 2,4-dinitrotoluene (2,4DNT) into soil,
groundwater or surface water. It has been reported that 2,4DNT can induce toxic effects on humans and other
organisms. However the mechanism of 2,4DNT induced toxicity is still unclear. Although a series of methods for
gene network construction have been developed, few instances of applying such technology to generate pathway
connected networks have been reported.
Results: Microarray analyses were conducted using liver tissue of rats collected 24h after exposure to a single oral
gavage with one of five concentrations of 2,4DNT. We observed a strong dose response of differentially expressed
genes after 2,4DNT treatment. The most affected pathways included: long term depression, breast cancer
regulation by stathmin1, WNT Signaling; and PI3K signaling pathways. In addition, we propose a new approach to
construct pathway connected networks regulated by 2,4DNT. We also observed clear dose response pathway
networks regulated by 2,4DNT.
Conclusions: We developed a new method for constructing pathway connected networks. This new method was
successfully applied to microarray data from liver tissue of 2,4DNT exposed animals and resulted in the
identification of unique dose responsive biomarkers in regards to affected pathways.
Background
2,4-Dinitrotoluene (2,4DNT), which has been found to
contaminate both soil, surface water and groundwater,
is used in production of polyurethane foam, propellants
and as a plasticizer in explosives [1]. 2,4DNT has been
found to be toxic to reproductive organs in rats [2] and
cause genetic toxicity in munitions facility workers and
copper miners using explosives [3,4]. DNTs including
2,4DNT are listed as a priority pollutant by the U.S.
Environmental Protection Agency [3]. It is therefore
important to develop methods to biomonitor people and
animals exposed to nitrotoluenes to prevent such poten-
tial harmful effects.
Toxicogenomics using microarray technology has
recently been applied to 2,4DNT and other military
compounds to understand its molecular mechanisms
[5-10]. While little information exists on the molecular
pathways affected by 2,4DNT in mammals, mechanisms
of 2,4DNT toxicity have been explored in the ecotoxico-
logical fish model Pimephales promulas. Expression
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tified molecular pathways involving oxidation of hemo-
globin and alteration of lipid metabolism via peroxisome
proliferative activator receptor alpha signaling as being
involved in 2,4DNT induced toxicity [8,11].
In toxicogenomics, molecular expression pattern
changes of cells occur as a result of exposure to toxi-
cants and give insight into how toxicants act and cause
disease. Nonetheless, many of these patterns are com-
plex, interconnected, and reflect a dynamic process evol-
ving from exposure to disease. Therefore, it is necessary
to develop a systems approach to studying toxicoge-
nomics by integrating ‘omics’ measurements with public
domain knowledge and interpreting them with a com-
putational approach that encodes such a comprehensive
biological context [12]. Examples of such knowledge
integration applied to systems biology include gene
ontology analysis [13], protein-protein interaction net-
work analysis [14], biological pathway analysis [15], and
visualization of complex biological networks [16]. How-
ever, few successful examples have been demonstrated
in toxicogenomics.
In this work, we aim to study systems-level functional
toxicogenomic changes induced by 2,4DNT exposure,
using rat liver as an experimental model. We employ a
new comprehensive pathway database resource, the
Human Pathway Database (HPD) (Chowbina, Wu et al.
2009), which contains a comprehensive collection of
human annotated and predicted pathway data. We
mapped significantly-changed expression patterns of rat
genes to human genes, and used HPD pathways to help
us interpret complex interconnected gene expression
patterns. We compared different dose effects of 2,4-
DNT and the broad pathway-level changes the
compound induced. To connect changes brought into
different pathways, we further constructed a pathway-
connecting-network (PCN) specific to differentially
expressed genes induced by 2,4-DNT. This systems-level
toxicogenomics study enables us to identify four major
pathways implicated with 2,4-DNT induced cellular
toxicity including long-term depression, breast cancer
regulation by stathmin1, retinol metabolism, and WNT
signaling. Genes significantly involved in these processes
include PPP2R2B, PLCB1, CACNA1D, PTPRD, PTPRG,
and RDH16.
Results
Dose responsive differentially expressed genes in rat liver
after 2,4DNT exposure
Female Sprague-Dawley rats were dosed with vehicle
control (5% DMSO in corn oil) or 2,4DNT at 4.98, 49.8,
99.5, or 199 mg/kg. After 24 hrs, rats were sacrificed,
livers harvested and gene expression examined in liver
using whole genome microarrays. Compared to controls,
samples treated with 2,4DNT had many differentially
expressed genes (DEGs) (Table 1). Genes were selected
for further analysis only if they passed the following cri-
teria: false discovery rate < 5%, fold change > 2 and q-
value < 0.05. The DEGs in the fourth column are those
genes which have a higher expression amount than con-
trol samples. Notably, a clear dose response relationship
was observed between increasing dose and increasing
numbers of DEGs. However, no significant effect on
transcription was observed at the lowest dose of
2,4DNT after 24 hrs.
Pathway analysis using genes differentially expressed at
each concentration of 2,4DNT
We used DEG data from 49.8, 99.5, and 199 mg/kg
exposures to build dose-specific protein- protein asso-
ciation matrix and dose-response networks in addition
to using the Human Pathway Database (HPD) to iden-
tify potential pathways affected by 2,4DNT [17]. The
driving motivation is that knowledge of these pathways/
protein-protein interaction networks will help clarify
and interpret physiological responses to 2,4DNT. A
novel algorithm was devised to generate a pathway-pro-
tein frequency count matrix (PPFCM) using DEGs from
each of the three doses of 2,4DNT (Figure 1). A PPFCM
contains pathways on the vertical axis and doses on the
horizontal axis. Each cell of PPFCM corresponds to the
count of proteins (mapped from) at a particular dose for
a given pathway. The pathways affected by 2,4DNT
were ranked in a descending manner based on the sum
of DEGs at ‘ALL’ doses. The PPFCM indicated that sig-
nal transduction, neurological, and metabolic pathways
were impacted including long-term depression, breast
cancer regulation by stathmin1, WNT signaling, and
PI3K signaling.
Dose responsive pathway connected networks
The top 20 pathways identified by PPFCM analysis and
derived from HPD were used to build a pathway mer-
ging network with pathway similarity scores for each
dose (Figure 2). To merge the top 20 pathways, we used
the concept of pathway similarity and applied a minimal
Table 1 Statistical analysis of microarray results
Dose
(mg/kg)
FDR
(< 5%)
Median no. of
false positives
No. of significant
differentially expressed
genes relative to controls
(q-value < 0.05)
4.98 0 0 0
49.8 4 4.72 117
99.5 4.55 59.43 1260
199 4.66 189.59 4148
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Page 2 of 8Figure 1 Protein frequency count matrix (PPFCM) generated using differentially expressed genes at three doses of 2,4DNT treatment.
[a] 266 pathways in the pathway. The vertical axis contains pathways from the Human Pathway Database (ref) pathways and doses, rounded to
nearest whole number, on the horizontal axis. Each cell of PPFCM corresponds to the count of proteins at a particular dose for a given pathway.
[b] Snapshot of top 25 pathways. The pathways are ranked in a descending manner based on the sum of DEGs at ‘ALL’ doses.
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Page 3 of 8Figure 2 Pathway merging network of top 20 enriched pathways affected by 2,4DNT treatment at each of the three doses. The
network was derived from differentially expressed genes (DEGs) across all doses of 2,4DNT. The size of each node is proportional to the number
of proteins in a pathway. The color of each node reflects the intensity of the DEGs in each pathway with darker shades of red indicating greater
numbers of DEGs. The edge label width is proportional to the number of molecular entities shared by the connected pathways.
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Page 4 of 8pathway similarity threshold [Si,j ≥ 0.2, and |Pi ∩Pj| > 1],
i=1...N, j=1...N. At this threshold, two pathways are con-
sidered connected if at least 20% minimal molecular
entities are shared and there is no less than 1 shared
entity. Only pathway pairs with a similarity score and
overlap above the threshold [Si,j ≥ 0.2, AND |Pi ∩ Pj|
>1] are shown.
T h r e ed a t as o u r c e s ,w e r eu s e dt og e n e r a t eac o m p r e -
hensive perspective of pathways which might be affected
by 2,4DNT. The network corresponding to dose 99.5
mg/kg can be further represented at gene level as shown
in Figure 3. The genes and full names are: (a) PPP2R2B
- Serine/threonine-protein phosphatase 2A 55 kDa regu-
latory subunit B beta isoform; (b) PLCB1 - 1-phosphati-
dylinositol-4,5-bisphosphate phosphodiesterase beta-1;
(c) CACNA1D -Voltage- dependent L-type calcium
channel subunit alpha-1D; (d) PTPRD - Receptor-type
tyrosine- protein phosphatase delta; (e) PTPRG -
Receptor-type tyrosine-protein phosphatase gamma; and
(f) RDH16 - Retinol dehydrogenase 16.
Discussion
In this manuscript, we identified biological pathways
and processes that may be biomarkers of 2,4DNT expo-
sure, determined genotoxic effects of 24DNT and
hypothesized its mechanism of action at the pathway
level.
Work in this study involves pathway-based network
analysis using DEGs in liver tissue of animals exposed
to 3 different concentrations of 2,4DNT. All the DEGs
are visualized as a pathway - protein frequency count
matrix (PPFCM). The PPFCM generated using these
DEGs upon 24DNT treatment shows the top four path-
ways induced: (a) long term depression; (b) breast can-
cer regulation by stathmin1; (c) retinol metabolism; and
(d) WNT Signaling. The PI3K pathway is an intricate
Figure 3 Location of 2,4DNT impacted genes in the pathway association network. Select genes that are differentially expressed in 99.5
mg/kg 2,4DNT exposures are indicated by blue arrows. PPP2R2B = Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta
isoform. PLCB1 = 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-1. CACNA1D = Voltage-dependent L-type calcium channel
subunit alpha-1D. PTPRD = Receptor- type tyrosine-protein phosphatase delta; PTPRG = Receptor-type tyrosine-protein phosphatase gamma.
RDH16 = Retinol dehydrogenase 16.
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Page 5 of 8signaling cascade that regulates cell survival and growth
under normal, as well as pathological conditions. In fact,
the PI3K pathway is mutated in more cancer patients
than any other [18]. The signaling network is balanced
by the PTEN tumor suppressor protein. PTEN (Phos-
phatase and Tensin Homologue Deleted from Chromo-
some-10) is recognized as one of the most frequently
mutated tumor suppressors in human cancer and has
also been associated with neurological diseases like aut-
ism [19].
Figure 1 contains important pathways responsible for
maintaining essential functions of normal cells. GSK3
and WNT signaling pathways are known for their roles
in embryogenesis and cancer, but they are also involved
in normal physiological processes in adult animals.
GSK3 is a key regulator in several physiological pro-
cesses such as cell cycle, oncogenesis and apoptosis in
neuronal cells and VSMC (Vascular Smooth Muscle
C e l l s )d u r i n gh y p o x i a[ 2 0 ] .G S K - 3 b( as p l i c ev a r i a n t )
plays a key inhibitory role in the Wnt signaling pathway.
Wnt genes encode a large family of secreted, cysteine-
rich proteins that are important in development and in
maintenance of adult tissues. Abnormalities in Wnt sig-
naling are reported to promote both human degenera-
tive diseases and cancer [21].
Abnormalities in pathways that use GSK-3 as a regula-
tor have been linked to several disease conditions, parti-
cularly in non-insulin-dependent diabetes mellitus,
Alzheimer’s disease, developmental disorders, and can-
cer [22]. A decrease in both GSK3 and WNT signaling
pathways may therefore be a mechanism contributing to
carcinogenesis upon 2,4DNT insult. The above observa-
tions validate the existing knowledge and provide new
leads to discover the action of 2,4DNT. Pathways such
as these also hint that primary targets of 2,4DNT’s toxi-
city are the hematopoietic, cardiovascular, nervous and
reproductive system.
A pathway merging diagram has been developed using
the top 20 pathways from the pathway - protein fre-
quency count matrix (PPFCM). This causal network
shows concordance with pathways affected or diseases
caused by 2,4DNT exposure and gives clues about other
diseases. The network involves pathways such as ERK,
PI3K and AKT signaling known to be involved in leuke-
mia and bladder cancer which are also diseases asso-
ciated with the cytotoxic effects of 2,4DNT. The
presence of other pathways such as ‘calcium signaling
pathway’ and ‘retinol metabolism’ may indicate addi-
tional diseases caused due to the mutagenic effects of
2,4DNT. This network may therefore warrant further
investigation to discover novel effects of 2,4DNT.
Our reported observations strengthen the necessity of
integrating pathways from heterogeneous sources and
also validate the existing literature knowledge. HPD
pathways in this study provide a good meta-model that
connects our fragmented pathway knowledge together
in pathway merging networks. A global perspective, sup-
ported by integration of otherwise incompatible path-
ways from different sources, enhances the chance of
exposing novel insights in the search for disease drug
targets and biomarkers. Our results provide clues about
the mechanism action of energetic compounds such as
2,4DNT and explain their genotoxic effects at the path-
way level.
These findings strongly support the potential of this
framework for evaluating functional genomics data
using pathway networks. In addition to validating exist-
ing literature findings; new knowledge can be derived by
adopting the methods used in our case study.
Material and methods
Chemicals
2,4DNT (97%) was purchased from Sigma-Aldrich (St.
Louis, MO).
Animals and treatment
Female Sprague-Dawley rats (175-225 grams) were from
the in- house breeding colony (College of Pharmacy,
University of Louisiana at Monroe [ULM] and treated in
accordance with the Guide for Use and Care of Animals
[23]. Breeders were from Harlan-Sprague Dawley in
Madison, WI. Housing consisted of a 12 h light/dark
cycle with ad libitum access to tap water and rodent
chow (Harlan/Teklad 7012, Madison, WI). Rats were
housed individually in polycarbonate cages on hardwood
bedding (Sani-chips, Harlan/Tekland, Madison, WI) one
week prior to treatment. Food was withdrawn the night
before treatments [vehicle control (5% DMSO in corn
oil), or one of four doses (4.98, 49.8, 99.5, or 199 mg/
k g )o f2 , 4 D N Ti n5 %D M S Oi nc o r no i l ]w h i c hw e r e
administered by gavage between 8 and 10 AM. Study
protocols were preapproved by the ULM Animal Care
and Use Committee.
Microarray experimental design
Changes in gene expression were tested using Agilent
commercial whole rat genome microarrays (4 X 44K).
In this project, four doses plus a vehicle control were
employed for 2,4-DNT at 24h. The dose selection was
based on the LD 50 data for each compound. Except
controls, the lowest dose, the second lowest dose, the
second highest dose and the highest dose were selected.
Four biological replicates of this design were conducted,
each using different animals.
Total RNA extraction
Total RNA was extracted from about 30mg of liver tis-
sue. Tissues were homogenized in the lysis buffer with
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gen). Total RNA concentrations were measured using a
NanoDrop® ND-1000 Spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA). The integrity and
quality of total RNA was checked on an Agilent 2100
Bioanalyzer (Palo Alto, CA). The gel-like images gener-
ated by the Bioanalyzer show that total RNAs have two
bands, representing the 18S and 26S RNA of mamma-
lian RNA . Nuclease-free water (Ambion) was used to
elute total RNA.
Microarray hybridization
Rat whole genome oligo arrays in the format of 4X44K
were purchased from Agilent Technologies. Sample
cRNA synthesis, labeling, hybridization and microarray
processing were performed according to manufacturer’s
protocol “One-Color Microarray-Based Gene Expression
Analysis” (version 1.0). The labeling reactions were per-
formed using the Agilent Low RNA Input Linear Ampli-
fication Kit in the presence of cyanine 3-CTP. The
labeled cRNA from each labeling reaction was hybri-
dized to individual arrays at 65 °C for 17 hours using
Agilent’s Gene Expression Hybridization Kit. After
washing, the arrays were scanned using a GenePix
4200AL scanner (Molecular Device Inc., Sunnyvale,
CA). The Feature extraction software (V. 9.5.1) from
Agilent was used to automatically find and place micro-
array grids, reject outlier pixels, accurately determine
feature intensities and ratios, flag outlier pixels, and cal-
culate statistical confidences.
Microarray data pre-processing
Microarray data analyses were processed with Gene-
Spring version 7.0 and 10.0. The sample quality control
was based on the Pearson correlation of a sample with
other samples in the whole experiment. If the average
Pearson correlation with other samples was less than
80%, the sample was excluded for further analysis. If the
scanned intensity was less than 5.0 for a probe, it was
transformed to 5. A perchip (within) array normalization
was performed using 50 percentile values of all the
probe values in the array. Per gene (between) array nor-
malization was also applied using the median value of a
gene across all samples in the experiment. Probe fea-
tures were first filtered using flags. A “present” or
“absent” flag was defined using the Agilent Feature
Extraction 9.5.1 software. Only a probe that had present
flags in at least 50% samples of all the arrays was kept
for further analyses. Data were subsequently log (base 2)
transformed for statistical analyses.
Rat Microarray Analysis
We use genome-scale gene expression data of liver cells
from rats treated with 4.98, 49.8, 99.5, or 199 mg/kg
2,4DNT to perform pathway analysis using human path-
way database (HPD) (Chowbina, Wu et al. 2009), build
dose-specific protein-protein association matrix and
dose- response networks. Therefore, the driving motiva-
tion is that knowledge of these pathways / protein-pro-
tein interaction networks will help clarify and interpret
physiological responses to 2,4DNT, which will advance
our understanding of the health consequences of
2,4DNT treatment.
Significant Analysis of Microarray (SAM)
Significance analysis of microarrays SAM software [24]
was used in two-class mode to determine the list of
genes best able to distinguish genes in control and each
of the three 2,4DNT dose groups which were run on
separate Microsoft Excel spreadsheets. The log (base 2)
normalized gene expression data of rat liver was
imported into a SAM plug-in of Microsoft Excel. The
SAM method (Tusher, Tibshirani et al. 2001), uses a
modified t-test statistic, with sample-label permutations
to evaluate statistical significance. Delta was chosen to
limit the output gene list so that fewer than 5% pre-
dicted false-positives are included. Significant positively
and negatively correlated genes whose mean expression
in the 2,4DNT group is greater or lesser than those in
the CONTROL group with a fold change of at least 2
and q-value less than 0.01 are selected for further analy-
sis. Differentially expressed genes for each dose are
uploaded into HPD [17] and these genes are visualized
as a pathway – protein frequency count matrix
(PPFCM) using the TIGR MeV (MultiExperiment
Viewer) [25].
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